IMG in Talks to Buy ICM's Classical Music Division

Classic Arts News   IMG in Talks to Buy ICM's Classical Music Division
 
The classical music management agency IMG Artists is in talks to buy International Creative Management's classical music division, reports The New York Times.

The tip came from an anonymous source, who told the paper that senior executives from both companies have met to discuss a possible transaction.

Along with CAMI (Columbia Artists Management), ICM and IMG are the biggest players in the classical music market.

IMG has a large and impressive artist roster including (among many others) such high-powered singers as Ren_e Fleming, Karita Mattila, Deborah Voigt, Anna Netrebko, Susan Graham, Lorraine Hunt Lieberson, David Daniels, Andreas Scholl, Thomas Hampson and R_ne Pape; instrumentalists Leif Ove Andsnes, Murray Perahia, Piotr Anderszewski, Lang Lang, Joshua Bell, Hilary Hahn, Evelyn Glennie and the Emerson String Quartet; conductors Franz Welser-M‹st, Vladimir Jurowski, Ivšn Fischer and Yuri Temirkanov; and composers Steve Reich (with his ensemble), Thomas Ads and (the company's newest acquisition) John Adams.

Among the musicians ICM represents are Yo-Yo Ma, Midori, Nadia Salerno-Sonnenberg, Wynton Marsalis, Emanuel Ax, Radu Lupu, Daniel Barenboim (as pianist), Ian Bostridge, Nathan Gunn, the Hagen and Tokyo String Quartets, Marin Alsop, Mariss Jansons, David Robertson and Robert Spano, as well as composer Osvaldo Golijov.

ICM focuses on movies, book publishing, television and popular music; classical music is something of a sideline. As the Times points out, 10 percent of a top opera singer's nightly fee of approximately $15,000 is peanuts compared with the $20 million payout the firm might receive for representing a movie star.

Texas financier Barrett Wissman, a former pianist married to cellist Nina Kotova, bought control of IMG Artists in 2003.


Recommended Reading:
 X

Blocking belongs
on the stage,
not on websites.

Our website is made possible by
displaying online advertisements to our visitors.

Please consider supporting us by
whitelisting playbill.com with your ad blocker.
Thank you!